| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10067-016-3446-Z |
| P698 | PubMed publication ID | 27783235 |
| P2093 | author name string | Jakob Kjellberg | |
| Mikkel Østergaard | |||
| Rikke Ibsen | |||
| Poul Jennum | |||
| Bente Appel Esbensen | |||
| Katrine Løppenthin | |||
| P2860 | cites work | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update | Q26859134 |
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Does socioeconomic status affect outcomes in early inflammatory arthritis? Data from a canadian multisite suspected rheumatoid arthritis inception cohort | Q30870000 | ||
| Physical inactivity in patients with rheumatoid arthritis: data from twenty-one countries in a cross-sectional, international study | Q33312586 | ||
| Two-year direct and indirect costs for patients with inflammatory rheumatic joint diseases: data from real-life follow-up of patients in the NOR-DMARD registry | Q34249182 | ||
| What is the impact of early rheumatoid arthritis on the individual? | Q34254558 | ||
| The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. | Q34328415 | ||
| Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont | Q34547981 | ||
| Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial | Q34651182 | ||
| Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab | Q34658023 | ||
| Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies | Q34889152 | ||
| Variation in the spillover effects of illness on parents, spouses, and children of the chronically ill. | Q35016871 | ||
| Evolution of cost structures in rheumatoid arthritis over the past decade. | Q35352526 | ||
| Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries | Q35552992 | ||
| Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study | Q35554227 | ||
| Is rheumatoid arthritis disappearing? | Q35554758 | ||
| Comorbidities in rheumatoid arthritis | Q36942648 | ||
| Economic consequences of established rheumatoid arthritis and its treatment | Q36942653 | ||
| Quantifying the economic burden of productivity loss in rheumatoid arthritis | Q37829809 | ||
| The economic burden of gout: A systematic review. | Q38442564 | ||
| Lower education and living in countries with lower wealth are associated with higher disease activity in rheumatoid arthritis: results from the multinational COMORA study | Q39371943 | ||
| Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial. | Q39434912 | ||
| Cost-effectiveness of biologic compared with conventional synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Register study | Q39646869 | ||
| Bone edema on magnetic resonance imaging is an independent predictor of rheumatoid arthritis development in patients with early undifferentiated arthritis | Q39761544 | ||
| Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. | Q40455661 | ||
| Cost-effectiveness of TNF inhibitors vs synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a Markov model study based on two longitudinal observational studies | Q41601731 | ||
| Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study | Q41942207 | ||
| Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial. | Q43073143 | ||
| Direct medical expenditure associated with rheumatoid arthritis in a nationally representative sample from the medical expenditure panel survey | Q43461275 | ||
| Costs of rheumatoid arthritis during the period 1990-2010: a register-based cost-of-illness study in Sweden | Q44918475 | ||
| The Danish National Health Service Register | Q46774707 | ||
| Disease activity and severity in patients with rheumatoid arthritis: relations to socioeconomic inequality | Q50144849 | ||
| Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study. | Q50714335 | ||
| The impact of low family income on self-reported health outcomes in patients with rheumatoid arthritis within a publicly funded health-care environment. | Q50747195 | ||
| Social conditions and self-management are more powerful determinants of health than access to care. | Q50866860 | ||
| Quantification of reduced health-related quality of life in patients with rheumatoid arthritis compared to the general population. | Q51752631 | ||
| The needs of patients with arthritis: the patient's perspective. | Q52174093 | ||
| The effect of rheumatoid arthritis on the quality of life of primary caregivers. | Q53531817 | ||
| Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twe | Q56420565 | ||
| 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q56506042 | ||
| Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis | Q57788596 | ||
| Functional disability in rheumatoid arthritis patients compared with a community population in Finland | Q60261143 | ||
| The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study | Q73342276 | ||
| Rheumatoid arthritis | Q74541001 | ||
| Work disability in early rheumatoid arthritis | Q76347798 | ||
| The disease process and utilization of health services in rheumatoid arthritis: the relative contributions of various markers of disease severity in explaining consumption patterns | Q79319452 | ||
| Rheumatoid arthritis and spondyloarthropathies: geographical variations in prevalence in France | Q79373047 | ||
| The economic burden of disease: comparison between rheumatoid arthritis and ankylosing spondylitis | Q84703433 | ||
| P433 | issue | 3 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 517-525 | |
| P577 | publication date | 2016-10-25 | |
| P1433 | published in | Clinical Rheumatology | Q15754927 |
| P1476 | title | Welfare costs in patients with rheumatoid arthritis and their partners compared with matched controls: a register-based study | |
| P478 | volume | 36 |
Search more.